Start-up Phenomic AI has raised $US$1.5 millionm from AI and biotechnology investors to identify cells growing abnormally and to evaluate the effectiveness of treatment by analysing microscopy data using deep learning. Computer vision tools allow researchers to spot early signs of disease by comparing cells. The company is working with a scientist at Canada's Hospital for Sick Children to develop an algorithm that spots changes in cells as they become cancerous. Phenomic AI founder, Oren Kraus, developed DeepLoc software during his PhD, which the company uses to speed up the time between gathering data and understanding it.
Start-up Phenomic AI has raised $1.5m from AI and biotechnology investors to identify cells growing abnormally and to evaluate the effectiveness of treatment by analysing microscopy data using deep learning. Computer vision tools allow researchers to spot early signs of disease by comparing cells. The company is working with a scientist at Canada's Hospital for Sick Children to develop an algorithm that spots changes in cells as they become cancerous. Phenomic AI founder, Oren Kraus, developed DeepLoc software during his PhD, which the company uses to speed up the time between gathering data and understanding it.